Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Prostanoid IP antagonists and their use in bladder disorders reported by Roche

Nov. 6, 2002

Tadalafil reported safe and effective in broad-spectrum erectile dysfunction

Nov. 5, 2002

TAP Pharmaceutical submits NDA for Uprima for ED

Nov. 4, 2002

Promising laboratory results for phosphate-lowering RenaZorb

Nov. 4, 2002

Keryx extends international manufacturing and negotiating rights for KRX-101

Oct. 30, 2002

A-278637: enhanced bladder selectivity and potency as compared to other KCOs

Oct. 29, 2002

FDA accepts Oxytrol NDA for filing

Oct. 29, 2002

FDA accepts Striant NDA for review

Oct. 23, 2002

Small-molecule MC4 receptor agonist with effects on food intake and erectile activity

Oct. 21, 2002

Columbia and Ardana enter European marketing partnership for Striant

Oct. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...